Jiangxi Bank Receives Regulatory Approval for Capital and Financial Bond Issuance

Stock News
08/05

JIANGXI BANK (01916) has announced it has received regulatory approvals to issue capital replenishment bonds and ordinary financial bonds in both domestic and overseas markets.

The bank received the People's Bank of China's "Permit of Administrative Licensing Decision" (Document No. 70 [2026]), authorizing the issuance of capital replenishment bonds in the national interbank market and overseas markets. The administrative license is valid until June 30, 2027, with the new balance of capital replenishment bonds not exceeding RMB 4 billion at the end of the validity period, and the total balance of such bonds not exceeding RMB 12 billion. JIANGXI BANK may choose to issue these bonds in installments at its own discretion within the validity period.

Additionally, the bank received another "Permit of Administrative Licensing Decision" (Document No. 71 [2026]), approving the issuance of ordinary financial bonds (including those with specific fund-raising purposes) in the same markets. This license is also valid until June 30, 2027, with the new balance of ordinary financial bonds limited to no more than RMB 2 billion at the end of the period, and the total balance capped at RMB 16 billion. The bank retains the flexibility to issue these bonds in installments during the validity period.

Furthermore, JIANGXI BANK recently received the "Jiangxi Financial Regulatory Bureau's Approval for the Bank to Issue Capital Instruments" (Document No. 142 [2026]), which permits the issuance of capital instruments worth up to RMB 11 billion. These instruments include perpetual capital bonds and subordinated tier-2 capital bonds. The bank is authorized to determine the timing, tranches, and scale of issuance within the approved quota, and must complete the issuance within 24 months following the approval.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10